Clinical candidate drugs of Gan Li Pharmaceutical Co., Ltd. were certified as orphan drugs by FDA

36 krypton learned that Ganli Pharmaceutical Co., Ltd. announced that glr2007, the company’s candidate drug for clinical phase I, was granted orphan drug qualification by the food and Drug Administration of the United States. This drug is used in the treatment of glioblastoma multiforme to study the drug safety, tolerance and optimal drug delivery strategy in patients with advanced solid tumor. Cai Shaofen stopped pregnancy for the first time. The 4 indexes on the B-ultrasound sheet in the early pregnancy were used to see whether the fetal development was good or not